- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.71 Å
- Oligo State
- monomer
- Ligands
- 1 x 6ON: 2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]-~{N}-[2-[2-[2-[2-[2-[2-[2-[2-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]ethanamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tanaka, M. et al., Design and characterization of bivalent BET inhibitors. Nat.Chem.Biol. (2016)
- Release Date
- 2016-07-06
- Peptides
- Bromodomain-containing protein 4: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A